tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Ownership - Who Owns Inhibikase Therapeutics?

101 Followers

Inhibikase Therapeutics (IKT) Ownership Overview

74.60%1.87%0.50%23.03%
74.60%
Insiders
0.50% Other Institutional Investors
23.03% Public Companies and
Individual Investors
The ownership structure of Inhibikase Therapeutics (IKT) stock is a mix of institutional, retail and individual investors. Approximately 2.37% of the company’s stock is owned by Institutional Investors, 74.60% is owned by Insiders and 23.03% is owned by Public Companies and Individual Investors.
The ownership structure of Inhibikase Therapeutics (IKT) stock is a mix of institutional, retail and individual investors. Approximately 2.37% of the company’s stock is owned by Institutional Investors, 74.60% is owned by Insiders and 23.03% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
94,193Institution1.31%128,102
27,688Institution0.38%37,656
16,724Institution0.23%22,745
11,000Institution0.15%14,960
1,913Institution0.03%2,602

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
94,193Institution1.31%128,102
27,688Institution0.38%37,656
11,000Institution0.15%14,960
1,913Institution0.03%2,602

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
16,724Institution0.23%30,772

FAQ

Who Owns Inhibikase Therapeutics (IKT)?
According to the latest TipRanks data, approximately 0.50% of the company's stock is held by institutional investors, 74.60% is held by insiders, and 23.03% is held by retail investors.
    What percentage of Inhibikase Therapeutics (IKT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.50% of Inhibikase Therapeutics (IKT) stock is held by institutional investors.
      What percentage of Inhibikase Therapeutics (IKT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 23.03% of Inhibikase Therapeutics (IKT) stock is held by retail investors.
        Who owns the most shares of Inhibikase Therapeutics (IKT)?
        VANGUARD INDEX FUNDS owns the most shares of Inhibikase Therapeutics (IKT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis